M Shiozawa
Overview
Explore the profile of M Shiozawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiraide K, Kanemura Y, Kaneshima R, Kashiwagi Y, Sato K, Shiba H, et al.
Phys Rev Lett
. 2025 Feb;
134(1):011801.
PMID: 39913709
The Super-Kamiokande and T2K Collaborations present a joint measurement of neutrino oscillation parameters from their atmospheric and beam neutrino data. It uses a common interaction model for events overlapping in...
2.
Iguchi K, Sato S, Shiozawa M, Mushiake H, Uchiyama M, Numata K, et al.
Tech Coloproctol
. 2024 Jul;
28(1):82.
PMID: 38981897
Background: Although functional end-to-end anastomosis (FEEA) using a stapler in the colorectal field has been recognised worldwide, the technique varies by surgeon, and the safety of anastomosis using different techniques...
3.
Abe K, Bronner C, Hayato Y, Hiraide K, Hosokawa K, Ieki K, et al.
Phys Rev Lett
. 2024 Jul;
132(24):241803.
PMID: 38949341
We report a search for time variations of the solar ^{8}B neutrino flux using 5804 live days of Super-Kamiokande data collected between May 31, 1996, and May 30, 2018. Super-Kamiokande...
4.
Abe K, Hayato Y, Hiraide K, Ieki K, Ikeda M, Kameda J, et al.
Phys Rev Lett
. 2023 Oct;
131(15):159903.
PMID: 37897794
This corrects the article DOI: 10.1103/PhysRevLett.130.031802.
5.
Yasui H, Okita Y, Nakamura M, Sagawa T, Watanabe T, Kataoka K, et al.
ESMO Open
. 2023 Sep;
8(5):101636.
PMID: 37703596
Background: Chemotherapy in combination with anti-epidermal growth factor receptor (EGFR) antibody is considered a first-line treatment regimen for RAS wild-type and left-sided metastatic colorectal cancer (mCRC), whereas second-line treatment regimens...
6.
Abe K, Akhlaq N, Akutsu R, Ali A, Alonso Monsalve S, Alt C, et al.
Eur Phys J C Part Fields
. 2023 Sep;
83(9):782.
PMID: 37680254
The T2K experiment presents new measurements of neutrino oscillation parameters using protons on target (POT) in (anti-)neutrino mode at the far detector (FD). Compared to the previous analysis, an additional...
7.
Abe K, Hayato Y, Hiraide K, Ieki K, Ikeda M, Kameda J, et al.
Phys Rev Lett
. 2023 Feb;
130(3):031802.
PMID: 36763398
We report a search for cosmic-ray boosted dark matter with protons using the 0.37 megaton×years data collected at Super-Kamiokande experiment during the 1996-2018 period (SKI-IV phase). We searched for an...
8.
Sunakawa Y, Satake H, Usher J, Jaimes Y, Miyamoto Y, Nakamura M, et al.
ESMO Open
. 2022 Jun;
7(3):100512.
PMID: 35688061
Background: Few prospective studies have used liquid biopsy testing in RAS-mutant metastatic colorectal cancer (mCRC), and its clinical significance remains unknown. Therefore, this study aimed to carry out a biomarker...
9.
Takahashi T, Yamazaki K, Oki E, Shiozawa M, Mitsugi K, Makiyama A, et al.
ESMO Open
. 2021 Mar;
6(2):100093.
PMID: 33744811
Background: Although the efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) against metastatic colorectal cancer (mCRC) has been demonstrated, little is known about its effectiveness upon disease stratification by RAS mutations....
10.
Sato S, Sugano N, Shiozawa M, Uchiyama M, Kazama K, Kato A, et al.
Tech Coloproctol
. 2021 Jan;
25(2):223-227.
PMID: 33459968
Background: Complete mesocolic excision with central vessel ligation may be important for accurate staging and improving the prognosis of right-sided colon cancer. Although the procedure is often performed laparoscopically, approaching...